Amphastar Pharmaceuticals (AMPH) Operating Income Growth (5y) (2018 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Operating Income Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.34% |
| Mar 31, 2026 | 5.75% |
| Dec 31, 2025 | 65.37% |
| Sep 30, 2025 | 48.41% |
| Jun 30, 2025 | 75.05% |
| Mar 31, 2025 | 37.89% |
| Dec 31, 2024 | 184.69% |
| Sep 30, 2024 | 88.39% |
| Jun 30, 2024 | 124.28% |
| Mar 31, 2024 | 76.51% |
| Dec 31, 2023 | 103.55% |
| Sep 30, 2023 | 95.42% |
| Jun 30, 2023 | 70.82% |
| Mar 31, 2023 | 40.21% |
| Dec 31, 2022 | 88.29% |
| Sep 30, 2022 | 58.15% |
| Jun 30, 2022 | 62.59% |
| Mar 31, 2022 | 72.77% |
| Dec 31, 2021 | 47.68% |
| Sep 30, 2021 | 33.70% |